Holding(s) in Company

RNS Number : 4522I

Allergy Therapeutics PLC

11 March 2010

 



TR-1:               notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:	Allergy Therapeutics plc
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights		X
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights		X
3. Full name of person(s) subject to the notification obligation:	Highclere International Investors Limited
4. Full name of shareholder(s) (if different from 3.):	The Highclere International Investors International Smaller Companues Fund The Highclere (Jesrsey) International Investors International Smaller Companues Fund
5. Date of the transaction and date on which the threshold is crossed or reached:	9 March 2010
6. Date on which issuer notified:	9 March 2010
7. Threshold(s) that is/are crossed or reached:                  Above 4%

8. Notified details
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the Triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of voting rights
			Direct	Direct	Indirect	Direct	Indirect
GB00B02LCQ05	11,683,057 11,683,057		12,851,363	12,85,363			4.15%

B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date	Exercise/ Conversion  Period/ Date	Number of voting rights that may be acquired if the instrument is exercised/ converted	% of voting rights
N/A	N/A	N/A	N/A	N/A

Total (A+B)
Number of voting rights	% of voting rights
12,851,363	4.15%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Not Applicable

Proxy Voting:
10. Name of the proxy holder:	Highclere International Investors Limited
11. Number of voting rights proxy holder will cease to hold:	N/A
12. Date on which proxy holder will cease to hold voting rights:	N/A

13. Additional information:	Highclere International Investors Limited ("Highclere") acts as an investment manager for the clients detailed in Question 4 above (our "Clients"). In acting for our Clients, Highclere are given full discretion over their investments and are empowered to vote on their behalf. However, we do not act as our Client's custodian and therefore shares are not held in our name but in the nominee name of their custodian bank
14. Contact name	Fergus Gilmore, Compliance Officer
15. Contact telephone number	0207-258-9845

 

END

 

 

HOLUAASRRAAOAAR